NCT05303337View on ClinicalTrials.gov

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
HIV Infections
Interventions
OTHER

Stool sampling

Stool samples will be collected from participants at baseline and W52

OTHER

Blood plasma collection

Blood plasma collection to assess persistent inflammation, immune activation and HIV reservoir at baseline,W24,W52

Trial Locations (1)

13003

RECRUITING

Hôpital Européen Marseille, Marseille

All Listed Sponsors
lead

Hôpital Européen Marseille

OTHER